CA Patent

CA2905496A1 — Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant

Assigned to ForSight Vision4 Inc · Expires 2014-09-25 · 12y expired

What this patent protects

Therapeutic agent delivery formulations for the sustained release of therapeutic agents from a Port Delivery System (PDS) implant is described in this application.

USPTO Abstract

Therapeutic agent delivery formulations for the sustained release of therapeutic agents from a Port Delivery System (PDS) implant is described in this application.

Drugs covered by this patent

Patent Metadata

Patent number
CA2905496A1
Jurisdiction
CA
Classification
—
Expires
2014-09-25
Drug substance claim
No
Drug product claim
No
Assignee
ForSight Vision4 Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.